Bay Street News, October, 2024

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES (SEE “OFFER AND DISTRIBUTION RESTRICTIONS” BELOW). CALGARY, Alberta, […]

MONTREAL, Oct. 09, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company […]

SARASOTA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a biopharmaceutical company committed to developing novel […]

WINSTON-SALEM, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a late clinical-stage biotech company focused on the […]

BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the […]

THE WOODLANDS, Texas, Oct. 09, 2024 (GLOBE NEWSWIRE) — Howard Hughes Holdings Inc. (NYSE: HHH) (“the Company” or “Howard Hughes”) […]

BOCA RATON, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) — Springbig, the leading provider of loyalty and marketing solutions for the […]

LOS ALTOS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]

Multinational Consumer Goods Company Enters into aCommercially Scalable Pilot with SemiCab Serving the Indian Market Fort Lauderdale, FL, Oct. 09, […]

KT-621 has demonstrated dupilumab-like activity and was well tolerated ina wide variety of preclinical models of TH2 diseases KT-621 is […]